You are here
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
SBC: HVMN Inc. Topic: SOCOM17C001
In the setting of altitude-induced hypoxia, operator cognitive capacity degrades and can compromise both individual and team performance. This degradation is linked to falling brain energy (ATP) levels and an increased reliance on anaerobic energy production from glucose. Ketone bodies are the evolutionary alternative substrate to glucose for brain metabolic requirements; previous studies have sho ...STTR Phase I 2018 Department of DefenseSpecial Operations Command
SBC: REJUVENATE BIO INC Topic: SOCOM17C001
Special Operations Forces (SOF) are an integral aspect of the US military. SOF operators are among the most elite and highly qualified individuals in the U.S. military. As such, extraordinary physical and mental demands are placed upon them to excel in extreme environments for extended periods of time. This unrelenting cycle of combat deployments and intense pre-deployment training shortens the fu ...STTR Phase I 2018 Department of DefenseSpecial Operations Command
SBC: Flow Pharma, Inc. Topic: CBD18A002
Flow Pharma, Inc. is a biotechnology company in the San Francisco Bay Area developing fully synthetic cytotoxic T lymphocyte (CTL)stimulating peptide vaccines for Marburg virus. The FlowVax vaccine platform allows us to create dry powder formulations of biodegradablemicrospheres and TLR adjuvants incorporating class I and class II T cell epitopes. FlowVax vaccines can be designed for delivery by i ...STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
Hybrid DNN-based Transfer Learning and CNN-based Supervised Learning for Object Recognition in Multi-modal Infrared ImagerySBC: TOYON RESEARCH CORPORATION Topic: 1
On this effort Toyon Research Corp. and The Pennsylvania State University are developing deep learning-based algorithms for object recognition and new class discovery in look-down infrared (IR) imagery. Our approach involves the development of a hybrid classifier that exploits both transfer learning and semi-supervised paradigms in order to maintain good generalization accuracy, especially when li ...STTR Phase I 2018 Department of DefenseNational Geospatial-Intelligence Agency
SBC: Sarcos Group LC Topic: A05161
A new dual pump hydraulic supply designed to enable energetically autonomous exoskeleton robots will be developed, tested and demonstrated. This new hydraulic supply will be integrated with a high performance hydraulically actuated full body exoskeleton robot and used to test and demonstrate the overall performances of such systems. New control policies that include: (i) an assist mode, where the ...STTR Phase II 2017 Department of DefenseSpecial Operations Command
SBC: Systems & Technology Research LLC Topic: SOCOM18A001
Face recognition performance using deep learning has seen dramatic improvements in recent years. This improvement has been fueled in part by the curation of large labeled training datasets with millions of images of hundreds of thousands of subjects.This results in effective generalization for matching over pose, illumination, expression and age variation, however these datasets have traditionally ...STTR Phase I 2018 Department of DefenseSpecial Operations Command
SBC: PATHOVACS INCORPORATED Topic: CBD18A001
The focus of this STTR phase I component is on proof-of-concept studies demonstrating applicability of technical approaches for identificationof circulatory diagnostic markers for infectious disease. Therefore, the primary objective of this project is to determine feasibility of one suchtechnical approach called Proteomics-based Expression Library Screening (PELS), for identification of pathogen-d ...STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
SBC: MAPP BIOPHARMACEUTICAL, INC. Topic: CBD18A002
There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terriblemorbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditionalvaccines have proven to be a huge contribution to public health, they do have some limitations especially in the cont ...STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
SBC: SOAR TECHNOLOGY INC Topic: A13068
With the advanced capabilities planned by the TALOS program comes the risk of the operator becoming overwhelmed by the information available and the operation of the suit itself. To effectively employ the suit in the field, TALOS requires an effective situational awareness display and an intuitive, low-impact way of interacting with the suits physical/sensor systems. SoarTech proposes to continue ...STTR Phase II 2016 Department of DefenseSpecial Operations Command
SBC: OTHER LAB, INC. Topic: NSF13599
A critical aspect of exoskeleton control that has to date introduced a performance limitation is the ability of the exoskeleton to recognize the intent of the operator so it can apply assistance to their desired motion. This intent recognition effort is typically solved using ad-hoc methods where subject matter experts make design decisions and tune transitions to identify intended maneuvers as re ...STTR Phase II 2016 Department of DefenseSpecial Operations Command